ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00916214
Recruitment Status : Completed
First Posted : June 9, 2009
Last Update Posted : June 14, 2011
Sponsor:
Collaborator:
Ministry of Health and Prevention
Information provided by:
Ringkobing Love Apotek

Brief Summary:
The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. The specific objective of the project is to determine effects of pharmaceutical care program on medication adherence and persistence among elderly polypharmacy users.

Condition or disease Intervention/treatment Phase
Polypharmacy Other: Pharmaceutical care program Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program
Study Start Date : June 2009
Actual Primary Completion Date : June 2011
Actual Study Completion Date : June 2011

Arm Intervention/treatment
Experimental: Intervention Other: Pharmaceutical care program
The pharmaceutical care program consists of 2 elements, that includes individualized medication education and regular follow up



Primary Outcome Measures :
  1. change in medication adherence from run-in to the end of phase 1 [ Time Frame: 6 months ]
  2. persistence of mean medication adherence [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Both men and woman aged more than 65 years and taking more than 2 drugs

Exclusion Criteria:

  • Inhabitants of nursing homes
  • People receiving unit dose dispensing of medicine

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00916214


Locations
Denmark
Ringkøbing Løve Apotek
Ringkøbing, Denmark, 6950
Sponsors and Collaborators
Ringkobing Love Apotek
Ministry of Health and Prevention
Investigators
Principal Investigator: Muhammad Saeed Ringkøbing apotek

Responsible Party: Muhammad Saeed, Ringkøbing Løve Apotek
ClinicalTrials.gov Identifier: NCT00916214     History of Changes
Other Study ID Numbers: RLA Trial
First Posted: June 9, 2009    Key Record Dates
Last Update Posted: June 14, 2011
Last Verified: September 2009